For postop early stage breast, long break equals no more XRT for you IMHO. So disease site matters, treatment goal matters, etc. That said...
Would like to get advice on how to compute for additional MU/fraction for treatment in case of 2-3 weeks non-treatment due to machine problems.
At the outset, note that as you have to add more BED to make up for lost time, the BED for late effects does not decrease (on account of the break; ie with short breaks late effect BEDs don't go down). The time factor decreases the BED-Gy10 by 0.5/day. There is no time factor for late BED-Gy3 effects. For a head/neck case to 70/35:
Tumor control no break = 70*(1+2/10)-(49/2) = 59.5
Tumor control w 3 week break, no Rx change = 70*(1+2/10)-((49+21)/2)=49
This suggests you need to increase the dose by ~20% to make up for the 3 week break, which would equal 84 Gy/42 fractions. That means about 7 treatment days, or 9 elapsed days; but you will need to add some dose on top because the extra treatment takes time too. So let's just say 86 Gy/43 fractions: Regis' final answer.
86/70 = 23% dose increase
Late effects no break = 70*(1+2/3) = 117
Late effects to make up for break = 86*(1+2/3) = 143
This means late effect risks will (intuitively) go up by ~23% as well if you try to account for the time break. One assumes in a HN case the cord max would go from 45 Gy to 55 Gy if you just run the Rx ahead 8 more fractions than planned. Is that OK? Probably. Only you can decide!